Related Experiment Videos
A point mutation at codon 13 of the N-ras oncogene in a human stomach cancer
Abstract:
A surgically removed human stomach cancer with the histological diagnosis of poorly differentiated adenocarcinoma contained an activated N-ras oncogene detected by an in vivo selection assay in nude mice using transfected NIH3T3 cells. Analysis using synthetic 20-mer oligonucleotide probes revealed a point mutation from G to C at the first letter of codon 13 of the N-ras gene resulting in the substitution of arginine for glycine. This is the first observation of an activated N-ras oncogene in human stomach cancers.
Insights
Researchers discovered an activated N-ras oncogene in human stomach cancer. A specific mutation was identified, marking the first observation of this activated oncogene in gastric adenocarcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric adenocarcinoma is a significant global health concern.
- Oncogene activation plays a crucial role in cancer development.
- The N-ras oncogene's role in human stomach cancer is not well-established.
Purpose of the Study:
- To investigate the presence and nature of N-ras oncogene activation in human stomach cancer.
- To identify specific mutations within the N-ras gene in gastric adenocarcinoma samples.
Main Methods:
- Surgical removal and histological diagnosis of human stomach cancer (poorly differentiated adenocarcinoma).
- In vivo selection assay in nude mice using transfected NIH3T3 cells to detect oncogene activation.
- Analysis of the N-ras gene using synthetic 20-mer oligonucleotide probes to identify point mutations.
Main Results:
- Detection of an activated N-ras oncogene in the human stomach cancer sample.
- Identification of a specific point mutation (G to C) at codon 13 of the N-ras gene.
- This mutation results in the substitution of glycine with arginine.
Conclusions:
- This study reports the first observation of an activated N-ras oncogene in human stomach cancer.
- The identified mutation in codon 13 of N-ras may contribute to the development of gastric adenocarcinoma.
- Further research is warranted to explore the implications of N-ras activation in stomach cancer.